VEGFA and Hypertension: Injection of NaHS was demonstrated to ameliorate soluble FMS-like tyrosine kinase 1 (sFlt1)-induced hypertension, proteinuria, and glomerular endotheliosis in rats by increasing vascular endothelial growth factor (VEGF) expression (28).